Yersinia enterocolitica as a vehicle for a naked DNA vaccine encoding Brucella abortus bacterioferritin or P39 antigen

Infection and Immunity

Volumn 70, Issue 4, 2002, Pages 1915-1923

  Al Mariri, Ayman ^a   Tibor, Anne ^a   Lestrate, Pascal ^a   Mertens, Pascal ^a   De Bolle, Xavier ^a   Letesson, Jean Jacques ^a  

^a UNIVERSITY OF NAMUR   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIOFERRITIN; DNA VACCINE; P39 ANTIGEN; UNCLASSIFIED DRUG; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRUCELLA ABORTUS; BRUCELLOSIS; CELLULAR IMMUNITY; CONTROLLED STUDY; CPG ISLAND; HUMORAL IMMUNITY; INTERFERON PRODUCTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; TH1 CELL; YERSINIA ENTEROCOLITICA;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; BRUCELLA VACCINE; CARRIER PROTEINS; CYTOCHROME B GROUP; FEMALE; FERRITINS; IMMUNIZATION; IMMUNOGLOBULIN G; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; PERIPLASMIC BINDING PROTEINS; VACCINES, DNA; VACCINES, SYNTHETIC; VEHICLES; YERSINIA ENTEROCOLITICA;

EID: 0036128601     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.70.4.1915-1923.2002     Document Type: Article

References (71)

1. Brucellosis
2. Lipopolysaccharide O side chain of Yersinia enterocolitica O:3 is an essential virulence factor in an orally infected murine model
3. Protection of BALB/c mice against challenge with B. abortus 544 by vaccination with BFR or P39 recombinant proteins adjuvanted with CpG ODN
4. Induction of immune response in BALB/c mice with a DNA vaccine encoding bacterioferritin or P39 of Brucella spp.
5. Temporal development of protective cell-mediated and humoral immunity in BALB/c mice infected with Brucella abortus
6. The effect of reduced-dose Brucella abortus strain 19 vaccination in accredited dairy herds
7. Convenient agarose medium for simultaneous determination of the low-calcium response and Congo red binding by virulent strains of Yersinia enterocolitica
8. How to survive in the host: The Yersinia lesson
9. Brucellosis: A worldwide zoonosis
10. Yersinia enlerocolitica: Overview and epidemiologic correlates
11. Yersinia enterocolitica can deliver Yop proteins into a wide range of cell types: Development of a delivery system for heterologous proteins
12. Protective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles
13. Protection against Brucella melitensis or Brucella abortus in mice with immunoglobulin G (IgG), IgA, and IgM monoclonal antibodies specific for a common epitope shared by the Brucella A and M smooth lipopolysaccharides
14. Oral somatic transgene vaccination using attenuated S. typhimurium
15. Oral delivery of DNA vaccines using attenuated Salmonella typhimurium as carrier
16. Antigenic properties of peptidic mimics for epitopes of the lipopolysaccharide from Brucella
17. Characterization, occurrence, and molecular cloning of a 39-kilodalton Brucella abortus cytoplasmic protein immunodominant in cattle
18. Identification of the major T-cell antigens present in the Brucella melitensis B115 protein preparation, Brucellergene OCB
19. Delivery of antigenencoding plasmid DNA into the cytosol of macrophages by attenuated suicide Listeria monocytogenes
20. Delivery of DNA vaccines by attenuated intracellular bacteria
21. Gram-positive and Gram-negative bacteria as carrier systems for DNA vaccines
22. DNA vaccines
23. Elicitation of predictable immune responses by using live bacterial vectors
24. BALB/c mice infected with Brucella abortus express protracted polyclonal responses of both IgG2a and IgG3 isotypes
25. Comparison of T cell cytokines in resistant and susceptible mice infected with virulent Brucella abortus strain 2308
26. Nonspecific serological reactions in the diagnosis of bovine brucellosis: Experimental oral infection of cattle with repeated doses of Yersinia enterocolitica O:9
27. Recombinant attenuated bacteria for the delivery of subunit vaccines
28. Delivery of protein antigens and DNA by virulence-attenuated strains of Salmonella typhimurium and Listeria monocytogenes
29. Immunity and protection against Brucella abortus
30. Genetic vaccines: Strategies for optimization
31. Bacteria as gene delivery vectors for mammalian cells
32. DNA vaccines: Immunology, application, and optimization
33. The role of M cells in mucosal immunity
34. Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis
35. Rational live oral carrier vaccine design by mutating virulence-associated genes of Yersinia enterocolitica
36. Entry sites for oral vaccines and drugs: A role for M cells, enterocytes and dendritic cells?
37. Differences in immune responses induced by oral and rectal immunizations with Salmonella typhi Ty21a: Evidence for compartmentalization within the common mucosal immune system in humans
38. T cells and cytokines in intracellular bacterial infections: Experiences with Mycobacterium bovis BCG
39. The outer membrane component, YscC, of the Yop secretion machinery of Yersinia enterocolitica forms a ring-shaped multimeric complex
40. Current status of DNA vaccines in veterinary medicine
41. Humoral immune responses of Brucella-infected cattle, sheep, and goats to eight purified recombinant Brucella proteins in an indirect enzyme-linked immunosorbent assay
42. Humoral immunity in mice mediated by monoclonal antibodies against the A and M antigens of Brucella
43. Modulation of immune responses following antigen administration by mucosal route
44. Bacteriologic and histologic features in mice after intranasal inoculation of Brucella melitensis
45. Selection of phage displayed peptides recognized by monoclonal antibodies directed against the lipopolysaccharide of Brucella
46. Protection against Brucella abortus in mice with O-polysaccharide-specific monoclonal antibodies
47. The expanding universe of T-cell subsets: Th1, Th2 and more
48. Vaccination against Brucella
49. Illness in a veterinary student following accidental inoculation ofBrucella abortus strain 19
50. Much ado about M cells
51. RBlo T lymphocytes control intracellular Brucella abortus infection as demonstrated in major histocompatibility complex class I- and class II-deficient mice
52. Gene transfer in dendritic cells, induced by oral DNA vaccination with Salmonella typhimurium, results in protective immunity against a murine fibrosarcoma
53. Analysis of Brucella lipopolysaccharide with specific and cross-reacting monoclonal antibodies
54. Immune serum-mediated effects on brucellosis evolution in mice
55. Lactic acid bacteria as antigen delivery vehicles for oral immunization purposes
56. Oral vaccine delivery
57. Diagnosis of bovine brucellosis by skin test: Conditions for the test and evaluation of its performance
58. Recent advances with recombinant bacterial vaccine vectors
59. Attenuated bacteria as a DNA delivery vehicle for DNA-mediated immunization
60. Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization
61. Pathogenesis of Brucella
62. T lymphocyte mediated protection against facultative intracellular bacteria
63. Mucosal immunity to infection with implications for vaccine development
64. The impact of new technologies on vaccines
65. DNA vaccines
66. Oral immunization against cholera toxin with a live Yersinia enterocolitica carrier in mice
67. Characterization of a monoclonal antibody specific for Brucella smooth lipopolysaccharide and development of a competitive enzyme-linked immunosorbent assay to improve the serological diagnosis of brucellosis
68. Characterization of smooth lipopolysaccharides and O polysaccharides of Brucella species by competition binding assays with monoclonal antibodies
69. Specific bovine brucellosis diagnosis based on in vitro antigen-specific gamma interferon production
70. Infection of cattle with Yersinia enterocolitica O:9 a cause of the false positive serological reactions in bovine brucellosis diagnostic tests
71. Capacity of passively administered antibody to prevent establishment of Brucella abortus infection in mice